Allied-Bristol Life Sciences, LLC, a biopharmaceutical enterprise jointly owned by Allied Minds and Bristol-Myers Squibb Company, today announced that it has entered into a licensing agreement with Harvard University based on research and intellectual property developed in Professor Malcolm Whitman’s lab at the Harvard School of Dental Medicine.

Cofounded by Harvard computer scientists, company developed rapidly with support from OTD.

An international team of researchers has developed a method for fabricating nanoscale electronic scaffolds that can be injected via syringe.

New fund, targeting technologies in engineering and the physical sciences, helps launch companies in robotics, 3D printing, and materials discovery